Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Abel E. Vásquez"'
Autor:
Diego A. Díaz-Dinamarca, Michelle L. Salazar, Daniel F. Escobar, Byron N. Castillo, Bastián Valdebenito, Pablo Díaz, Augusto Manubens, Fabián Salazar, Mayarling F. Troncoso, Sergio Lavandero, Janepsy Díaz, María Inés Becker, Abel E. Vásquez
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The development of vaccine adjuvants is of interest for the management of chronic diseases, cancer, and future pandemics. Therefore, the role of Toll-like receptors (TLRs) in the effects of vaccine adjuvants has been investigated. TLR4 ligand-based a
Externí odkaz:
https://doaj.org/article/fe040994137a4fb786bc7c6c6b76ff8d
Autor:
Nicolás M. S. Gálvez, Catalina A. Andrade, Gaspar A. Pacheco, Jorge A. Soto, Vicente Stranger, Thomas Rivera, Abel E. Vásquez, Alexis M. Kalergis
Publikováno v:
Viruses, Vol 13, Iss 3, p 519 (2021)
Human metapneumovirus (hMPV) is one of the main pathogens responsible for acute respiratory infections in children up to 5 years of age, contributing substantially to health burden. The worldwide economic and social impact of this virus is significan
Externí odkaz:
https://doaj.org/article/290d23a222bd4c8e8214aad12c759482
Autor:
María Inés Becker, Michelle L Salazar, Diego Díaz-Dinamarca, Abel E Vásquez, Javiera Villar, Alejandra Alvarado, Byron Castillo, Daniel Navarro, Fabián Salazar, Augusto Manubens
Publikováno v:
The Journal of Immunology. 208:102.26-102.26
Hemocyanins are oligomeric glycoproteins widely used as immunomodulators because they bias immunity towards a Th1 profile when inoculated in mammals. We have demonstrated that hemocyanins are internalized through receptor-mediated endocytosis, and TL
Autor:
Diego A. Díaz-Dinamarca, Simone Cárdenas-Cáceres, Nicolás A. Muena, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Daniel F. Escobar, Michal Díaz-Samirin, Natalia T. Santis-Alay, Cecilia Canales, Janepsy Díaz, Heriberto E. García-Escorza, Alba Grifoni, Alessandro Sette, Nicole D. Tischler, Abel E. Vasquez
Publikováno v:
Vaccines, Vol 12, Iss 8, p 919 (2024)
The SARS-CoV-2 Omicron variant and its sublineages continue to cause COVID-19-associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and CoronaVac are the main vaccines used in Chile. Much less is known about the Wuhan-Hu
Externí odkaz:
https://doaj.org/article/6ea6a9ac2ef94f11bc2941087c63e5c0
Autor:
Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Loredana Arata, Jonnathan Grossolli, Boris Riveros-Rodriguez, Luis Ardiles, Julio Santelises, Valeria Vasquez-Saez, Daniel F. Escobar, Daniel Soto, Cecilia Canales, Janepsy Díaz, Liliana Lamperti, Daniela Castillo, Mychel Urra, Felipe Zuñiga, Valeska Ormazabal, Estefanía Nova-Lamperti, Rosana Benítez, Alejandra Rivera, Claudia P. Cortes, María Teresa Valenzuela, Heriberto E. García-Escorza, Abel E. Vasquez
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionSevere acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 millio
Externí odkaz:
https://doaj.org/article/c3f1849e5f704c2cbc2f0b56c662ecee
Autor:
Daniel F. Escobar, Diego A. Diaz-Dinamarca, Carlos F. Hernández, Daniel A. Soto, Ricardo A. Manzo, Pedro I. Alarcón, Camila H. Pinto, Diego N. Bastias, Carolayn N. Oberg-Bravo, Robert Rojas, Sebastián E. Illanes, Alexis M. Kalergis, Abel E. Vasquez
Publikováno v:
BMC Pregnancy and Childbirth, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Group B Streptococcus (GBS) is the leading cause of invasive neonatal infection. In this study, we aimed to evaluate the analytical validation of qualitative real-time polymerase chain reaction (qPCR) as a means to detect GBS. Met
Externí odkaz:
https://doaj.org/article/0f2929bf573e4fa1bdf241c0091af090
Autor:
Daniel F. Escobar, Pablo Díaz, Diego Díaz-Dinamarca, Rodrigo Puentes, Pedro Alarcón, Bárbara Alarcón, Iván Rodríguez, Ricardo A. Manzo, Daniel A. Soto, Liliana Lamperti, Janepsy Díaz, Heriberto E. García-Escorza, Abel E. Vasquez
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
In January 2021, the Chilean city of Concepción experienced a second wave of coronavirus 2019 (COVID-19) while in early April 2021, the entire country faced the same situation. This outbreak generated the need to modify and validate a method for det
Externí odkaz:
https://doaj.org/article/1141c5b204da49e2a03b18d3815ad7f8
Autor:
Diego A. Díaz-Dinamarca, Michelle L. Salazar, Byron N. Castillo, Augusto Manubens, Abel E. Vasquez, Fabián Salazar, María Inés Becker
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1671 (2022)
New-generation vaccines, formulated with subunits or nucleic acids, are less immunogenic than classical vaccines formulated with live-attenuated or inactivated pathogens. This difference has led to an intensified search for additional potent vaccine
Externí odkaz:
https://doaj.org/article/a79ffd4ac05b43c49d295b339fb52ba5
Autor:
Camila Covián, Ayleen Fernández-Fierro, Angello Retamal-Díaz, Fabián E. Díaz, Abel E. Vasquez, Margarita K. Lay, Claudia A. Riedel, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The Bacillus Calmette-Guérin (BCG) is a live attenuated tuberculosis vaccine that has the ability to induce non-specific cross-protection against pathogens that might be unrelated to the target disease. Vaccination with BCG reduces mortality in newb
Externí odkaz:
https://doaj.org/article/3179b301258c44ec9d5f5050389b39c8
Autor:
María José Altamirano-Lagos, Fabián E. Díaz, Miguel Andrés Mansilla, Daniela Rivera-Pérez, Daniel Soto, Jodi L. McGill, Abel E. Vasquez, Alexis M. Kalergis
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
The human respiratory syncytial virus (hRSV) is the main etiologic agent of severe lower respiratory tract infections that affect young children throughout the world, associated with significant morbidity and mortality, becoming a serious public heal
Externí odkaz:
https://doaj.org/article/efb484f2808a4c5988b81ffe676e612a